News
Earlier use of combination therapies is purported to improve outcomes in many disease states, including lupus nephritis.
Oral cancer is a growing public health concern, particularly in South Asia, where it affects tens of thousands each year. In ...
Viewing lupus decision aids without interruption leads to better patient-reported outcomes, regardless of whether they are ...
Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...
The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.
Magnetic resonance imaging (MRI) findings such as inflammatory-type lesions and myelopathies are significantly associated with attribution of neuropsychiatric (NP) events to systemic lupus ...
Hosted on MSN7d
The Link Between a Mother's Lupus and a Child's AutismThat work has revealed a possible connection between ASD and autoimmune conditions, including systemic lupus erythematosus ...
7d
BUCKSCO.Today on MSNGlaxosmithkline Gets Approval for First-of-its-Kind Lupus TreatmentGlaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...
From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.
“Lupus can make navigating everyday life difficult. The skin manifestation, known as lupus rash, often comes with persistent itching, which can lead to scarring and hair loss.
Enpatoran shows promising efficacy in lupus rash Merck’s investigational oral TLR7/8 inhibitor significantly improved skin disease activity in patients with cutaneous and systemic lupus erythematosus, ...
ROCKVILLE, Md., May 16, 2025 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results